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The multiple transferable resistance (mTR) pump from
Neisseria gonorrhoeaeMtrCDEmultidrug pump is assembled
from the inner and outer membrane proteins MtrD andMtrE
and the periplasmic membrane fusion protein MtrC. Previ-
ously we established that while there is a weak interaction of
MtrD and MtrE, MtrC binds with relatively high affinity to
both MtrD and MtrE. MtrD conferred antibiotic resistance
only when it was expressed with MtrE and MtrC, suggesting
that these proteins form a functional tripartite complex in
which MtrC bridges MtrD and MtrE. Furthermore, we dem-
onstrated that MtrC interacts with an intraprotomer groove
on the surface ofMtrE, inducing channel opening. However, a
second groove is apparent at the interface of the MtrE sub-
units, whichmight also be capable of engagingMtrC.We have
now established that MtrC can be cross-linked to cysteines
placed in this interprotomer groove and that mutation of res-
idues in the groove impair the ability of the pump to confer
antibiotic resistance by locking MtrE in the closed channel
conformation. Moreover, MtrE K390C forms an intermolec-
ular disulfide bond with MtrC E149C locking MtrE in the
open channel conformation, suggesting that a functional salt
bridge forms between these residues during the transition
from closed to open channel conformations. MtrC forms
dimers that assemble into hexamers, and electron micros-
copy studies of single particles revealed that these hexamers
are arranged into ring-like structures with an internal aper-
ture sufficiently large to accommodate the MtrE trimer.
Cross-linking of single cysteine mutants of MtrC to stabilize
the dimer interface in the presence ofMtrE, trapped anMtrC-
MtrE complex with a molecular mass consistent with a stoi-
chiometry of 3:6 (MtrE3MtrC6), suggesting that dimers of
MtrC interact with MtrE, presumably by binding to the two
grooves. As both MtrE and MtrD are trimeric, our studies
suggest that the functional pump is assembled with a stoichi-
ometry of 3:6:3.
Gram-negative bacteria utilize homologous tripartite trans-
port systems to pump cytotoxic compounds, including antibi-
otics, metals, and protein toxins, from the cell (1–6). These
assemblies are composed of an inner membrane protein
(IMP),6 which transduces electrochemical energy, and a con-
duit-forming outer membrane protein (OMP), which are con-
nected by a periplasmic membrane fusion protein (MFP),
anchored to the inner membrane (1–6). There are structures
for all of the individual components but not for a fully assembled
tripartite complex. For example, in the case of the AcrABTolC
multidrug pump and CusABC copper pump from Escherichia
coli, the structures of the RND transporters AcrB (7, 8) and
CusA (9), of their cognate MFPs, AcrA (10) and CusB (11), and
of OMPs, TolC (12), and CusC (13), have been determined.
IMPs, represented by AcrB and CusA, as well as the OMPs,
such as TolC and CusC, function as trimeric assemblies. There
is evidence that the periplasmic domains of AcrB and TolC
contact one another (14, 15), whereasAcrA stabilizes this inter-
action by binding across these proteins (14, 16). Cross-linking
studies indicate that the -helical coiled-coil hairpin7 of AcrA
fits into intraprotomer grooves of the open state of TolC,
whereas its -lipoyl domains interact with the periplasmic
domain of AcrB at the interface between adjacent subunits (17,
18). The latter interaction contrasts with that proposed for the
CusA, which has been modeled as interacting with the surface
of the CusB subunits, rather than at their interface (9). In such
models, the stoichiometry is 3:3:3, yet a fully assembled tripar-
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tite complex has not been cross-linked. It is also notable that the
hairpin of CusB is relatively short and could not make the same
extensive contacts with CusC as AcrA can with TolC, suggest-
ing that the interaction would primarily be at the periplasmic
tip of CusC. Recent studies of theMacABTolCmacrolide pump
from E. coli indicate that the MFP MacA forms a hexameric
channel that connects the periplasmic tips of MacB and TolC
(19, 20), implying that the tripartite assembly occurs with a
stoichiometry of 3:6:3. Most recently, the structure of a CusA-
CusB binary complex was reported, revealing a 3:6 assembly,
further suggesting that the MFP forms a channel between the
IMP and OMP (21).
Structural analysis of the OMPs reveals that each protomer
forms a structural repeat, which has arisen from an early gene
duplication event. Thus, each trimer of OMP in fact possesses a
pseudo-6-fold symmetry that translates into the creation of
three pairs of grooves, two pairs per protomer, one on the intra-
protomer, and one on the junction between the protomers,
each of which could act as an MFP interaction site. Several
studies, involving ITC (14), surface plasmon resonance (22),
and fluorescence recovery after photobleaching (23) measure-
ments ofMFP binding to theOMP, indicate that there aremul-
tiple binding sites, and some cross-linking studies suggest that
the MFP binds to a pair of grooves on the OMP (24). Also
supporting this proposal, a number of operons have been iden-
tified that encode the components of tripartite pumps that
include the genes for a pair of MFPs (25, 26). Because in some
cases both of theseMFPs are required for function of the pump
(25), this suggests that it is necessary for the OMP to bind both
MFPs, leading to the hypothesis that two MFPs bind to the
intra- and interprotomer grooves, respectively (26). Two recent
studies on the assembly of the AcrABTolC pump, reported
while our work was in progress, indicate that AcrA forms
dimers, but in one study, these were shown to bind to AcrB and
TolC, which interacted with one another (27), whereas in the
other study, these dimers were reported to form an hexameric
channel, interconnecting AcrB to TolC (28).
The determination of the stoichiometry of the pump assem-
bly and the dynamics of the interactions between the pump
components will be crucial in providing an understanding of
the molecular mechanism of their action that would aid in
developing novel pharmaceutical agents against drug resis-
tance, which is an emerging global problem. We have investi-
gated the assembly of the MtrCDE tripartite multidrug efflux
pump from Neisseria gonorrhoeae, which has the advantage
that all the components of the pump are encoded by the same
operon and, consequently, the interactions between the com-
ponents are likely to be specific, facilitating analyses of pump
assembly (29, 30). We present evidence for assembly of the
MtrD-MtrC-MtrE complex with a stoichiometry of 3:6:3, in
which MtrC binds to both intraprotomer and interprotomer
grooves on the surface of MtrE.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—The E. coli strains and plasmids used
are described in supplemental Table 1, and the primers used for
construction of plasmid vectors are described in supplemental
Table 2.
Site-directed Mutagenesis of mtrE—A QuikChange XL kit
(Stratagene) was used for site-directed mutagenesis of mtrC
and mtrE. For in vivo functional analyses of the pump, the
pACYCDuet-mtrC/mtrD/mtrE plasmid was used as the tem-
plate, whereas for the purification of MtrC and MtrE deriva-
tives, the pET-mtrE plasmid was used as the template, with the
primers given in supplemental Table 3 used to introduce the
required mutations into mtrC and mtrE. PCR reactions were
performed using the following cycling parameters: initial acti-
vation, 95 °C for 1 min; denaturation, 95 °C for 50 s; annealing,
55 °C for 50 s; and extension, 68 °C for 10min for 17 cycles, with
a final extension at 68 °C for 10 min. After PCR, the template
was digested with DpnI for 3 h, 5 l of the PCR mix was trans-
formed into NovaBlue E. coli, and colonies were selected for
chloramphenicol resistance. Plasmids were extracted from the
colonies, and their DNA was sequenced.
Protein Overexpression and Purification—All the proteins
used in this study were purified as fusion proteins with a six-
histidine tag from E. coli overexpressing strains according to
previously published protocols (30).
Growth Curve Analyses—E. coli cells, of strain (tolC)
TG1(DE3) (30, 31), harboring plasmids were grown at 37 °C
(200 rpm) until the cell density reached anA600 of 0.5, and then
induced with 1 mM isopropyl-1-thio--D-galactopyranoside.
The cells were grown for a further 3 h and diluted with 2YT
medium containing antibiotic, and the growth curve was
recorded; cells for minimum inhibitory concentration (MIC)
measurements were monitored for growth 24 h later.
In Vitro Cross-linking—MtrE and MtrC (8 M in 20 mM
Na2HPO4, pH 7.5, 100 mM NaCl, 10% glycerol, 0.05% DDM)
were mixed with 1 mM bis(maleimido)hexane (BMH), 1 mM
bis(maleimido)ethane, or 0.75mM dibromobimane (DBBR) (all
freshly prepared in N,N-dimethylformamide) and incubated at
25 °C for 1 h. The samples were reduced with 50 mM DTT,
mixed with 4 LDS sample buffer, boiled for 5 min, and sepa-
rated on 4–12% gradient SDSNuPAGE precast gel withMOPS
buffer. Similarly, 1 mM ethylene glycol bis-succinimidyl succi-
nate (EGS) cross-linker was used to test for dimers and higher
order oligomers of MtrC. Unless stated otherwise, the cysteine
insertion mutants were prepared using the genes encoding the
Cys-less MtrE C21S and NT-MtrC derivatives as the target for
further mutagenesis.
For pulldown of cross-linked complexes of MtrE and MtrC,
10l of 8MMtrE wasmixed with 0.5 ml of crude cell lysate,
which contained NT-MtrC, and the proteins were incubated
with 1 mM N-succinimidyl-3-(2-pyridyldithio)-propionate
(SPDP) or succinimidyl 6-(3-[2-pyridyldithio]-propionamido)-
hexanoate (LC SPDP) at 25 °C for 1 h, immobilized on Ni2-
Sepharose beads (50 l), and washed with increasing concen-
trations of imidazole (10–40 mM) before elution with 50 l of
500mM imidazole. Protein complexes were identified byWest-
ern blotting using both anti-His tag and anti-S tag antibodies.
In Vivo Cross-linking—E. coli cells (strain tolC TG1) were
grown in 2YT broth to anA600 nm of 0.5, induced with 0.5mM
isopropyl-1-thio--D-galactopyranoside, and incubated at
25 °C for a further 2 h. Cells were harvested, washed twice in
cross-linking buffer (20mMNa2HP04 (pH 7.5), 300mMNaCl, 1
mM EDTA, and 10% glycerol), resuspended in the same buffer
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with 1 mM BMH, and incubated at 25 °C for 1 h. Excess cross-
linker was then removed by washing the cells twice in the same
buffer. The cells were disrupted by sonication in the presence of
2 mg/ml N-ethylmaleimide, cell debris was removed by super-
speed centrifugation (using a TLA 100.4 rotor at 15k rpm), and
the membranes were isolated by ultracentrifugation (using a
TLA 100.4 rotor at 50,000 rpm). The membranes were solubi-
lized in cross-linking buffer, with 8M urea and 2% (w/v)DDM,
for 2 h at room temperature; 50l ofNi2-Sepharose beadswas
mixed with the membrane proteins and incubated at room
temperature for 1 h; the beads were washed with cross-linking
buffer containing 10–40 mM imidazole to remove nonspecific
contaminants, and target protein was elutedwith 500mM imid-
azole buffer containing 50 mM DTT followed by boiling the
beads at 100 °C for 10 min. The protein mixture was separated
on 4–12% NuPAGE (Invitrogen) and immunoblotted onto
PVDFmembranes, and cross-linked complexes were identified
with anti-His antibodies. Unless stated otherwise, the cysteine
insertion mutants were prepared using the genes encoding the
Cys-lessMtrEC21S andMtrCC25S derivatives as the target for
further mutagenesis.
Microcalorimetry—ITC measurements were carried out at
25 °C using a VP-ITC microcalorimeter (MicroCal). MtrC was
prepared in 20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% v/v
glycerol, whereas MtrE was prepared in the same buffer with
0.1%w/vDDM(buffer 1). After addingDDMtoNT-MtrC to
a final concentration of 0.1% (w/v), it was dialyzed, in different
dialysis cassettes, at the same time with MtrE against buffer 1.
An ITC experiment involvedmaking a single 2-l injection and
a series of 8-l injections of NT-MtrC from the syringe into the
cell, which contained the MtrE. All data were corrected for the
heat changes arising from injection of proteins into buffer
before data analysis with ORIGIN software (MicroCal). Exper-
iments were carried out in triplicate, and a statistical average
was taken.
Disc Diffusion Assays—E. coli cells were grown to an A600 of
about 0.5 and inducedwith 0.5mM isopropyl-1-thio--D-galac-
topyranoside, the cells were diluted to 0.1, and then 200 l of
cell culture was spread on an Mu¨ller-Hinton agar plate previ-
ously incorporated with 0.5 mM isopropyl-1-thio--D-galacto-
pyranoside; antibiotic discs were placed on the plate medium
and incubated at 37 °C overnight. The zone of culture growth
inhibition was determined. The discs used were impregnated
with 1 g/ml nafcillin, 30 g/ml tetracycline, 10 g/ml eryth-
romycin, 5 g/ml novobiocin, and 30 g/ml vancomycin.
Mass Spectrometry—Analyses were performed in a nanoflow
electrospray mass spectrometer QSTAR and Q-ToF-2 (Waters
Corp., Milford, MA). The following experimental parameters
were used on QSTAR to record mass spectra of the proteins
(generally at 10–20 mg/ml): capillary voltage up to 1.2 kV,
declustering potential 150 V, focusing potential 150 V, declus-
tering potential-2 15 V, and collision energy up to 70 V. In MS
mode, the following QToF-2 parameters were used for analysis
of the Mtr proteins: capillary voltage 1668 V, sample cone 150
V, extractor cone 0V, accelerating voltage into the collision cell
(termed collision energy as per the manufacturer’s terminol-
ogy) 150 V, ion transfer stage pressure 6.1  103 mbar, and
TOF analyzer pressure 1.0 104 mbar.
To identify MtrC and MtrE in samples run on SDS-PAGE
gels,MALDI-TOF PeptideMass Fingerprinting was performed
using a Voyager-DETM STR BioSpectrometryTM workstation
(Applied Biosystems, Warrington, UK). De-isotoped and cali-
brated spectrawere thenused to generate peak lists, whichwere
searched using the MASCOT mass spectrometry database
search software to identify the proteins.
Atomic ForceMicroscopy—Proteins for atomic force micros-
copy were diluted to a final concentration of 1g/ml, and 45l
of the sample was allowed to adsorb to freshly cleaved mica.
Imaging in air was performed with a multimode atomic force
microscope (Digital Instruments, Santa Barbara, CA) in tap-
ping mode. The silicon cantilevers containing a diamond-like
extratip had a drive frequency of 300 kHz and a specified
spring constant of 40 newtons/m (MikroMasch, Portland, OR),
and the applied imaging forcewas kept as low as possible (target
amplitude 1.6–1.8 V and amplitude set point 1.3–1.5 V).
The molecular volumes of the protein particles were deter-
mined from particle dimensions based on atomic force micros-
copy images using the SPIP software (Image Metrology).
Electron Microscopy—Protein samples (0.05 mg/ml, mixed
with glutaraldehyde (2.5% (v/v) final)) were applied to electron
microscope hydrophilic grids coated with carbon film and
stained with 2% uranyl acetate. The preparations were exam-
ined using a Philips CM120 electronmicroscope equippedwith
a LaB6 filament, with an acceleration voltage of 120 kV. Elec-
tron micrographs were taken at a magnification of 45,000.
Selected images were digitized with a step size of 12.5 m on a
Super COOLSCAN 9000 Nikon. The WEB and SPIDER soft-
ware package (Wadsworth Center, New York) was used for all
image processing.
Molecular Modeling—A molecular model for MtrE has pre-
viously been reported (30). A homology model for MtrC was
designed using the MexA (1T5E.pdb) and AcrA (2F1M.pdb)
structures as templates and the methodology previously
described for theMtrEmodel (30). Essentially, this consisted of
creating combined sequence and structural alignments using
T-Coffee (32) and Expresso3D (33), respectively, which were
manually analyzed, followed by homology model building with
Modeler (34), using the MexA (1T5E.pdb) and AcrA
(2F1M.pdb) structures as templates.
RESULTS
Previous cross-linking studies indicate that the MFP binds
within an intraprotomer groove, bounded by helices 3, 7, and 8
of the OMP (17, 18). However, a second groove is apparent at
the interface of the subunits within the OMP trimer, bounded
by helices 4 and 7 of adjacent subunits (12, 35), which could act
as a second site for binding the MFP. We sought to investigate
the role of the interprotomer groove ofMtrE, using a structural
model (Fig. 1A) that we had previously generated (30), to guide
mutagenesis of the groove residues. Using such an approach,
we previously established thatMtrC binds to the intraprotomer
groove of MtrE (30). Furthermore, our studies indicate that
MtrC communicates the binding of drugs to MtrD to MtrE,
presumably via a conformational change that induces opening
of the MtrE channel.
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Residues within the Intersubunit Groove of the MtrE Trimer
Affect the Pump Function—Anumber of pointmutations in the
intersubunit groove of MtrE were constructed based upon a
comparative analysis of the modeled structure of MtrE, identi-
fying conserved, solvent-accessible residues likely to be posi-
tioned on the surface of the groove (Fig. 1A). The antibiotic
sensitivity of these mutants was tested; this initial analysis indi-
cated that there was amodest increase in the sensitivity of these
mutants to a range of antibiotics (Table 1). This is perhaps not
surprising because single point mutations would not be
expected to block binding to the groove surface, which presum-
ably involves a number of interactions. Consequently, we tested
whether this effect was cumulative by constructing double
mutations; these double mutants were highly susceptible to
antibiotics, confirming that residues in the interprotomer
groove are important for pump function (Table 1).
We sought to further substantiate these findings by perform-
ing a growth curve analysis for each mutant in the presence of
tetracycline and nafcillin. These antibiotics were specifically
chosen because theymight identify how thesemutations impair
pump function; tetracycline targets the ribosome, and its
removal from the cytoplasm would be sufficient to confer
resistance, whereas nafcillin targets penicillin-binding proteins
in the periplasm, so that its removal from the cell would be
required to confer resistance. Our expectation was that muta-
tions that affected the interaction of MtrC with MtrE would
have a more pronounced effect on the growth of cells treated
with nafcillin than tetracycline. In the case of the single muta-
tions, the cells were clearly more susceptible to growth inhibi-
tion by nafcillin (Fig. 2B) than tetracycline (Fig. 2A). This sug-
gests that these MtrE derivatives were impaired in their ability
to interact withMtrCD. Considering that changing one residue
FIGURE 1. Homology models of the structure of MtrE and MtrC. To generate molecular models of MtrE and MtrC, combined sequence and structural
alignments were made using T-Coffee and Expresso3D, respectively, which were manually analyzed, followed by homology model building with Modeler,
using the MexA (1T5E.pdb) and AcrA (2F1M.pdb) structures as templates. A, the molecular model shows the position of the intra- and interprotomer grooves
(groove 1 and groove 2, respectively) and of the mutations introduced into the intersubunit groove (in the expanded panel) of the OMPMtrE. B, the molecular
model shows the position of the mutations introduced into the -helical coiled-coil hairpin domain of the MFP MtrC.
TABLE 1
The inhibitory zone determined by disc diffusionmethod formtrEmutants expressed with or withoutmtrC ormtrCD in E. coli (tolC) TG1(DE3)
cells
The indicatedMtr proteins were expressed from pACYC and/or pET21a in (tolC) TG1(DE3) E. coli cells. The inhibitory zone diameter is given inmm. The abbreviations
are: Naf, nafcillin; Tet, tetracycline; Ery, erythromycin; Nov, novobiocin; Van, Vancomycin; NI, no inhibition of growth; NG, no growth due to complete growth inhibition;
CL, cysteine-less;WT, wild type. * was used to signify when proteins were expressed from pET21a, which would confer resistance to nafcillin. All disc diffusion assays were
undertaken in triplicate, and the average result is given.
MtrE derivative Naf (1 g/ml) Tet (30 g/ml) Ery (10 g/ml) Nov (5 g/ml) Van (30 g/ml)
Vector control: pACYC 20 35 31 27 NI
MtrCD 12 26 22 19 NI
MtrCDE 12 25 20 19 NI
MtrCDE-K225E 14 30 31 24 NI
MtrCDE-Y228F 16 32 30 20 NI
MtrCDE-R235E 13 30 28 21 NI
MtrCDE-R239E 14 29 27 25 NI
MtrCDE-K390E 15 34 20 23 NI
MtrCDE-K397E 14 29 29 21 NI
MtrCDE-K225E/R239E 20 39 36 30 NI
MtrCDE-K225E/K390E 19 37 33 27 NI
MtrCE 17 31 25 20 NI
MtrCE-K225E/R239E 22 38 30 25 NI
MtrE-K225E/R239E NI* 26 26 17 NI
Vector control: pACYC pET21a NI* 40 35 25 NI
MtrC(CL)/MtrE(CL)MtrD(WT) NI* 26 21 17 NI
MtrC(CL)/MtrE(K390C)MtrD(WT) NI* 26 21 17 NI
MtrC(E149C)/MtrE(CL)MtrD(WT) NI* 26 21 17 NI
MtrC(E149C)/MtrE(K390C)MtrD(WT) NI* 40 35 25 11
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in the intersubunit groove might not be enough to severely
perturb the interaction ofMtrEwithMtrCD,we testedwhether
introducing double mutations would compound the effect on
the sensitivity of the cells to antibiotics. None of the double
mutants afforded any resistance to nafcillin (Fig. 2B). A West-
ern blot analysis indicated that this cannot be attributed to a
failure of theMtrE doublemutants to express; theMtrEK225E/
K390E andK225E/R239E derivatives were expressed at compa-
rable levels to wild-type MtrE, as were MtrC and MtrD with
which the MtrE derivatives were co-expressed (data not
shown). The nafcillin sensitivity of the MtrE double mutants
might hence be attributable to their inability to interact with
MtrCD. However, an ITC analysis revealed that MtrC not only
was capable of binding to theMtrEK225E/R239Ederivative but
did so with a 3-fold higher affinity than for the wild-type MtrE
(supplemental Fig. 1). Furthermore, we found that the double
mutants were also susceptible to tetracycline (Fig. 2A), which is
surprising because one might have expected that MtrCD could
confer resistance to tetracycline even in the absence of MtrE.
These data imply that the MtrE derivative interacts with
MtrCD but that the assembled MtrCDE pump is non-func-
tional. The nature of this assembly is, however, debatable. The
increase in affinity of the MtrE K225E/R239E derivatives for
MtrC might simply be attributable to MtrC being bound more
tightly at the interprotomer groove; however, it is possible that
with the interprotomer groove having been disrupted, MtrC
only binds to the intraprotomer groove, which has a higher
affinity than the interprotomer groove for the MFP. The non-
functionality of the pumpmight be attributable toMtrE adopt-
ing a constitutively open or closed state. In an attempt to dis-
tinguish between these possibilities, we tested the susceptibility
of the cells to vancomycin, which is too big to enter cells by
passive diffusion but can gain entry through an open OMP (30,
35). None of the mutants were susceptible to vancomycin
(Table 1 and Fig. 2C), indicating that the channel of MtrE was
closed. One possibility is that theMtrE derivatives are impaired
in their ability to open the channel and, as a consequence, the
mutants are susceptible to tetracycline and nafcillin, which can
diffuse into the cell, but are insensitive to vancomycin, which
cannot enter the cells. Indeed, we note that cells expressing
MtrCD alone confer greater resistance to nafcillin and tetracy-
cline than cells expressing MtrCD with MtrE K225E/K390E
and K225E/R239E (Fig. 2), indicating that these MtrE deriva-
tives interact with MtrCD to impair pump function. Consider-
ing that MtrCD can confer elevated resistance suggests that
they interact with an E. coli OMP other than TolC; such pro-
miscuous behavior has been noted for other tripartite pumps
(36). Presumably then, MtrE K225E/K390E and K225E/R239E
are bound more tightly by MtrCD than this E. coli OMP,
impairing pump function. Although cells expressing MtrCE
K225E/R239E were insensitive to vancomycin, they had
increased sensitivity to a range of transported antibiotics (Table
1), suggesting that the pump is leaky but not fully open (to
vancomycin).
Evidence for the Binding of MtrC to the Interprotomer Groove
of MtrE—To test whether MtrC interacts directly with the
intersubunit groove of MtrE, we replaced residues within the
groove with cysteines for cross-linking studies (Fig. 3). Hetero-
bifunctional cross-linkers SPDP and LC-SPDP, which react at
one end with a sulfhydryl group and at the other with a primary
amine group, were used to cross-link the His-tagged MtrE cys-
teine derivatives to S-tagged NT-MtrC, which was present in
the crude extract from disrupted cells. Cross-linked MtrE-
MtrC complexes were purified using Ni2-Sepharose beads
and identified by Western blotting using anti-S tag antibodies.
The K225C, R239C, and K390C derivatives of MtrE were all
found to form cross-linked dimers of MtrE-MtrC (Fig. 3), indi-
cating that MtrC binds along the length of the intersubunit
groove. Interestingly, the most abundant band had a molecular
mass of about 390 kDa, which would be too large for a 3:3
assembly but consistent with a 6:3 assembly ofMtrC andMtrE.
MtrC Oligomerizes to Form a Hexameric Structure—Most
models suggested that the MFPs function independently, each
bridging one protomer of the IMP and OMP, to form a tripar-
tite assembly composed of a trimeric IMP and OMP that are
FIGURE 2. Mutations in the interprotomer grooves of MtrE impair the
pump.A–C, bar charts showing the relative growth (measured as theA600 nm)
over 4 h for tolC TG1(DE3) cells expressing the mtrCD and mtrE genes,
including wild-type mtrE and a series of mtrE mutants in the interprotomer
groove as indicated, in the presence of 16 g/ml nafcillin (A), 3 g/ml tetra-
cycline (B), and 160g/ml vancomycin (C). The same strain transformedwith
the empty vector was used as a control. Each bar is the average of at least
three measurements, with error bars representing the S.D. of these measure-
ments from the average.
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coupled by three MFPs (18). Such a model would not require
that the MFPs interact with one another.
We used EGS to test for interactions, in vitro, betweenMtrC
hairpins, trapping complexes up to a hexamer (Fig. 4A). Nano-
flow electrospraymass spectrometry was used to determine the
molecular mass of the MtrC hairpin, revealing peak series con-
sistent with the hairpin monomer (9563 0 Da; the calculated
molecular mass of the MtrC hairpin is 9558.62 Da), dimer
(19,170 1Da), and hexamer (57,522 17Da) (Fig. 4B). It was
possible to visualize individual hairpins and ring-like structure
oligomers in solution by atomic force microscopy (Fig. 4C).
These particles had average molecular volumes of 41  1 and
243 5 nm3, respectively, which is also compatible with hexa-
meric hairpins. Similarly, cross-linking studies (Fig. 4D) and the
mass spectrum of NT-MtrC (N-terminal truncated, 1–34,
MtrC) indicated that it exists as amonomer (42,438 3Da; the
calculatedmolecular mass forMtrC is 43,822.75 Da) and that it
exists at oligomeric states up to the hexamer (254,709 10 Da)
(Fig. 4E). Interestingly, for both the MtrC hairpin and
NT-MtrC, following the appearance of monomers and dimers,
the hexameric state is the most abundant oligomeric species.
In addition, we were able to visualize the MtrC hexamers by
electron microscopy (EM), revealing a ring structure (Fig. 4F).
An inspection of the image of an averaged ring reveals that it
contains six semicircular subunits, which give rise to 12 protru-
sions (two per subunit). Applying a self-rotation function and
imposition of 6- and 12-fold averaging improved the detail of
the image, but the imposition of 3- or 9-fold averaging led to an
asymmetric image. These data are consistent with MtrC form-
ing a hexameric ring structure that could bridge MtrD and
MtrE. This partial dissociation of the helices of the hexameric
assembly could provide a mechanism to allow the helices to
overlap and engage with the helices of the OMP trimer because
this diameter (of 55 Å) would in principle be able to accommo-
date the MtrE trimer.
Evidence for the Formation of an MtrE(Trimer)-MtrC(Hex-
amer) Complex—Considering that there is a tendency for the
hairpin domains of MtrC to interact, we sought to test the
effects of stabilizing this interaction on the ability of MtrC
(dimers) to interact with MtrE. The D143C and E149C deriva-
tives of MtrC, in which a single cysteine was inserted into the
hairpin domain, underwent intermolecular cross-linking with
BMH to form dimers (Fig. 5, A and B, lane 10). In the presence
of MtrE, BMH cross-linking of MtrC trapped a number of high
molecular mass complexes (Fig. 5, A and B, lane 11), which
mass spectrometry analyses confirmed to contain both MtrC
and MtrE (MASCOT data not shown). Once formed, these
complexes appeared to be stable (supplemental Fig. 2). In the
case of E149C, these complexes were calculated to have masses
of 250, 330, and 400 kDa (Fig. 5B, lane 11), whereas D143C
had two bands, with apparent masses of 220 and 270 kDa,
instead of a band at 250 kDa. Considering that the MtrC dimer
and MtrE timer have molecular masses of 88 and 149 kDa,
respectively, a reasonable explanation for the occurrence of
these complexes is that they correspond to the MtrE trimer
binding one, two, and three dimers of MtrC (i.e.with predicted
molecular masses of 236, 324, and 412 kDa, respectively). Fur-
thermore, considering that the intra- and interprotomer
grooves ofMtrE are about 16 Å apart, they are sufficiently close
to allow BMH to bridge MtrC bound to these two grooves. In
contrast, these complexes could not be trappedwith the shorter
bifunctional cross-linker bis(maleimido)ethane (data not
shown).
Moreover, when the MtrC D143C and E149C derivatives
weremixedwithMtrE C21SK225C, these highmolecularmass
complexes were further stabilized by BMH cross-linking; six
bands with a molecular mass greater than the 247-kDa marker
were apparent, which were shown by mass spectrometry to
consist of bothMtrC andMtrE (supplemental Fig. 3).We found
similar cross-linking patterns for MtrC D143C and MtrC
E149C in combination with MtrE C21S K390C (data not
shown). These data are consistent with formation of cross-
linked complexes of the MtrE trimer with up to six MtrC mol-
ecules. This behavior is expected because the MtrC derivatives
can cross-link both as dimers, stabilizing the 2:3, 4:3, and 6:3
complexes, and with the MtrE derivatives, to additionally sta-
bilize the 1:3, 3:3, and 5:3 complexes of MtrC-MtrE. If the
MtrC:MtrE stoichiometry was 3:3, then the molecular mass of
these complexes would be about 270 kDa, much less than the
molecular mass of the largest complexes trapped by cysteine
cross-linking. Our findings are consistent with an MtrC:MtrE
stoichiometry of 6:3.
In Vivo Cross-linking of MtrC and MtrE Impairs Pump
Function—Considering that MtrC D143C and MtrC E149C
could be cross-linked to the interprotomer groove of MtrE, via
K225C and K390C, with BMH in vitro, these residues should
come sufficiently close to allowdirect disulfide bond formation.
We expressed each of the mtrC D143C, mtrC E149C, mtrE
K225C, andmtrE K390C mutants with their cognate wild-type
mtrC,mtrD, andmtrE genes intolCTG1 cells and tested these
for tetracycline resistance. ThemtrCD143C,mtrC E149C, and
FIGURE 3.AWestern blot analysis of the cross-linking ofMtrE derivatives
to NT-MtrC. His-tagged, cysteine-free (C21S) MtrE and its derivatives were
used as bait for S-tagged NT-MtrC; interactions were stabilized by SPDP or LC
SPDP, and boundNT-MtrCwas detected using anti-S tag antibodies. Approx-
imately 10l of 8MMtrEderivativewasmixedwith 0.5ml of crude cell lysate
containingNT-MtrCand incubatedwith1mMSPDPor LCSPDPat 25 °C for 1h;
50l ofNi2-Sepharosebeadswas added,washedwith10–40mM imidazole,
before proteinswere elutedwith 50l of 500mM imidazole, fromwhich 25l
was applied to a 4–12% polyacrylamide gel. The blot shows the high molec-
ular mass (390 kDa) MtrE-MtrC complex. The samples in the gel lanes are as
follows: 1) marker (MWmarker); 2) MtrC incubatedwith nickel-Sepharose (Ni-
beads); 3) MtrE-MtrC; 4) MtrE-MtrC SPDP; 5) MtrE-MtrC LC SPDP; 6) MtrE
K225C-MtrC; 7) MtrE K225C-MtrC SPDP; 8) MtrE K225C-MtrC LC SPDP; 9)
MtrE R239C-MtrC; 10) MtrE R239C-MtrC SPDP; 11) MtrE R239C-MtrC LC
SPDP; 12) MtrE K390C-MtrC; 13) MtrE K390C-MtrC  SPDP; and 14) MtrE
K390C-MtrC LCSPDP. Thepositions of relevantmolecularmassmarkers are
shown on the gel; the absence and addition of cross-linkers is indicated by
and, respectively.
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mtrEK390Cmutants had resistance to tetracycline comparable
with cells expressing the wild-type proteins, but the mtrE
K225C mutant had reduced resistance. Consequently, we
focused further analyses onmtrE K390C, which was expressed
with mtrC D143C and mtrC E149C and wild-type mtrD (Fig.
6A). Although the mtrE K390C/mtrC D143C mutant retained
resistance, themtrE K390C/mtrC E149C mutant was sensitive
to tetracycline. This behavior indicates that there is a detrimen-
FIGURE 4.MtrC and its hairpin domain forms hexamers. A andD, 1 mM EGSwas added to 8MMtrC hairpin (lane 2) (A) and 8MNT-MtrC (lanes 2 and 3) (D)
and analyzed by SDS-PAGE. Lane 1 in each gel indicates the molecular mass standard. MtrC and its hairpin were found to formmultimers up to and including
ahexamer.B and E, themass spectra of theMtrChairpin (B) andNT-MtrC (E) indicate that they formhexameric assemblies. The charge states of theMtrChairpin
(labeled 16 to 14) that correspond to ameasuredmass of 57,522 17Da (B) and oligomerization scheme are shown. In E, the charge states corresponding
to both the hexamer (labeled 35 to 30) with a measured mass of 254,709  10 Da and a low abundant pentamer with a mass of 212,259  10 Da are
illustrated. C, atomic force microscopy-generated three-dimensional pictures of low magnification images of the hairpin (left) and its multimer (right),below
whichare shown the frequencydistributionofmolecular volumesofMtrChairpinmonomers (left) andhexamers (right). In eachcase, the curve indicates a fitted
Gaussian function. The peaks correspond to volumes of 41  1 nm3 (n  100) and 243  5 nm3 (n  20), indicating that the hairpin forms hexamers.
F, EM-generated picture of the average top view of 336 selected images of NT-MtrC particles (top left panel), with the protein density contour level highlighted
(top right panel) and after the imposition of 6-fold symmetry. The box size is 280 Å, and the scale bar is 65 Å. The images indicate that MtrC forms a hexameric
ring structure, with outer and inner diameters of160 and 55 Å, correspondingly.
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tal interaction, presumably via the formation of a disulfide
bond, between MtrC E149C and MtrE K390C. We tested all of
the mutants for their susceptibility to vancomycin, revealing
that, in contrast to the other mutants, the mtrE K390C/mtrC
E149C mutant was sensitive to vancomycin (Fig. 6B). These
data indicate that the interaction of the MtrC E149C andMtrE
K390C derivatives locks MtrE in the open channel conforma-
tion. Indeed, ifMtrCE149C failed to interactwithMtrEK390C,
then the cells would be insensitive to vancomycin.
Considering thatMtrC E149C interacts withMtrE K390C in
vivo, we sought to confirm this interaction by cross-linking
these residues with BMH in vivo (Fig. 7). The His tag on MtrC
was used to purify and identify, byWestern blotting, the cross-
linked protein complexes. Two unique bands due to protein
cross-linkingwere detected in samples containingMtrC E149C
and MtrE K390C; no corresponding band was apparent when
thisMtrC derivativewas expressedwithCys-lessMtrE, indicat-
ing that these bands arise from cross-linking of MtrC to MtrE.
The lowermolecularmass bandwas present whether or not the
samples had been treated with BMH, whereas the other slightly
higher molecular mass band was only present in those samples
treated with BMH. Probably the complex with cross-linker
moved at a slightly higher molecular weight on the gel, as seen
for other proteins (37). MtrC D143C was also cross-linked to
MtrE K390C in a similar manner. Interestingly, both MtrC
D143C and E149C residues cross-linked to MtrE K390C in the
absence of BMH, indicative of the formation of intermolecular
disulfide bonds, which were resistant to reduction by 50 mM
DTT. Other periplasmic proteins have been reported that form
disulfide bonds that are resilient to reduction by reducing
agents (37). One possibility is that the residues forming the
disulfide bond become buried, in this case within the inter-
protomer groove, so that they are shielded from the DTT.
Evidence That the MtrC Hairpin Tip Scans along the Inter-
subunit Groove of MtrE—We hypothesized that if Cys-149 of
MtrC comes into close contact with Cys-390 of MtrE then we
should be able to cross-link the cysteine insertion derivatives of
these proteins using a bifunctional cross-linker with a much
shorter spacer arm than BMH, and that such a shorter cross-
linkerwould hinder the formation ofMtrCdimers that could be
positioned in the intra- and interprotomer grooves ofMtrE.We
tested whether DBBR, with a 5 Å spacer length, would cross-
linkMtrE K390C toMtrC E149C and/or D143C in vitro. Inter-
estingly, although an SDS-PAGE analysis did not reveal a
unique band that would confirm cross-linking of MtrE K390C
toMtrC E149C, two unique bands were apparent for the cross-
linking of MtrE K390C to MtrC D143C, with DBBR (Fig. 8A).
The higher molecular mass band was subjected to a
MALDI-MS analysis, revealing that it contained bothMtrC and
MtrE. The molecular mass of this band is suggestive of a com-
plex of MtrC monomer bound to MtrE trimer. We extended
this analysis by testing whether MtrC S141C, D143C, S146C,
and E149C derivatives could cross-link with the MtrE R235C
and R239C derivatives, which lie further up the intersubunit
groove. MtrC D143C, but none of the other derivatives, inter-
acted withMtrE R235C and R239C (Fig. 8B). Presumably, Asp-
143, positioned at the tip of the hairpin, is in a more flexible
position so that it can interact with several residues along the
interprotomer groove asMtrCdocks on toMtrE,whereas other
residues along the hairpin may only come into close contact
with groove residues as MtrC and MtrE become fully engaged
in the functional pump.
DISCUSSION
In the absence of a structure for a fully assembled tripartite
pump, the debate is still open on how the individual compo-
FIGURE 5. Evidence for the formation of an MtrC-MtrE complex with a stoichiometry of 6:3. A and B, an SDS-PAGE gel analysis of the cross-linking
of 8 M MtrC D143C (A) and 8 M MtrC E149C (B) with 1 mM BMH in the absence and presence of 8 M Cys-less (C21S) MtrE was undertaken with the
following samples: MtrE (lane 2), MtrC (lane 3), MtrE-MtrC (lane 4), MtrC D143C or E149C (lane 5), and MtrE-MtrC D143C or E149C (lane 6) in the absence
of BMH and MtrE (lane 7), MtrC (lane 8), MtrE-MtrC (lane 9), MtrC D143C or E149C (lane 10), and MtrE-MtrC D143C or E149C (lane 11) in the presence of
BMH. Lanes 1 and 12, and molecular mass standards. Complexes of MtrC and MtrE, identified by MS, are denoted as 1–5 in panel A and 1–3 in panel B. For
each gel lane, 20 l of 8 M of each protein/1 mM BMH solution was loaded onto 4–12% polyacrylamide gel. The positions of relevant molecular mass
markers are shown on the gel.
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nents interact with one another. Although some previous
cross-linking studies supported modeling of the assembly with
a stoichiometry of 3:3:3 and have since gained popularity (17,
18), some others, which have indicated an engagement in both
grooves (24), have been somewhat overlooked.However, recent
structural studies have handed further support to that hypoth-
esis. For example, the MFP MacA was shown to form a hex-
amer, the assembly of which was required for the interaction
with the cognate IMP MacB (19). This is consistent with the
finding that the MacB transporter functions as a homodimer
that interacts with trimeric TolC (38) because, although it is
very difficult to construct a centrally symmetric assembly with
only threeMFPs in this system, if we consider a hexameric IMP
assembly, then there is a trimer of MacB dimers within the
tripartite assembly, with eachMacBmonomer binding aMacA
molecule. Furthermore, it was proposed that the -domains of
FIGURE 6.An interactionbetweenMtrC E149CandMtrEK390C induces openingof theMtrE channel.A and B, A series of growth curves (A) and bar charts
(B), showing the relative growth measured as the A600 nm over 3.5 h, for E. coli cells (strain tolC TG1(DE3)) expressing themtrCDE genes, including wild-type
mtrC andmtrE as well as themtrCD143C,mtrC E149C, andmtrE K390Cmutants alone and in combination, in the presence of 3g/ml tetracycline (A) and 160
g/ml vancomycin (B). The same strain transformed with the empty vector was used as a control. The cysteine insertion mutants of mtrC and mtrE were
constructed in the Cys-lessmtrC C25S andmtrE C21S mutants so that disulfide bonds can only occur between the inserted cysteines. Each bar is the average
of at least three measurements, with error bars representing the S.D. of these measurements from the average.
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MacA interact with the periplasmic domain of MacB, whereas
the -helical hairpins form a connecting channel to TolC (19,
20). Recent structural studies of a CusAB complex have
revealed a hexamer of the MFP CusA bound to a trimer of the
IMPCusB, consistentwith this viewof theMacBAassembly (9).
The -domains of CusB form a cap over the periplasmic
domain of CusA, whereas the lipoyl and hairpin domains form
a channel. At its periplasmic end, defined by the hairpins, the
channel has an internal diameter of 56 Å but is constricted in
the region defined by the lipoyl domains to about 18Å, suggest-
ing that it forms a connecting channel to CusC. Considering
that CusC forms trimers, these data suggest that the CusABC
tripartite complex is assembled with a stoichiometry of 3:6:3.
Although these findings relate to the metal ion transporters,
they also bring into question whether similar stoichiometry
may be found in the classical multidrug pumps.
We have addressed this stoichiometry question by investi-
gating the assembly of the MtrCDE multidrug pump. Both the
IMPMtrD and theOMPMtrE form trimers (supplemental Fig.
4) (30), whereasMtrC can formhexamers (Fig. 4). Our previous
studies revealed thatMtrD interactsweaklywithMtrE,whereas
MtrC has a relatively strong interaction with MtrE and MtrD,
suggesting that these proteins form a tripartite complex in
which the interaction of MtrE and MtrD is stabilized by the
binding of MtrC across these proteins (30). Considering that
MtrC is anchored to the innermembrane by an-helix and that
the NT-MtrC has an affinity for MtrD that is an order of mag-
nitude greater than that forMtrE, this suggests that theMtrCD
complex is preformed ready for interaction with MtrE (30).
Here, we have shown that MtrC readily forms dimers, which
upon cross-linking are trapped in complex with MtrE, with a
stoichiometry of 3:6 (Fig. 5). Consistent with this behavior, we
provide evidence that MtrC binds to both intraprotomer and
interprotomer grooves on the surface of MtrE (30) (Figs. 3 and
7). Accordingly, our studies are consistent with the MtrCDE
tripartite pump being assembled with a stoichiometry of 3:6:3
and with a topology in which MtrD and MtrE contact one
another and MtrC is bound across these proteins (supplemen-
tal Fig. 5). This positions MtrC to detect drug binding to MtrD
and to communicate this toMtrE, inducing opening of its chan-
nel (30).
The emerging view of the MFPs, such as MacA and CusA,
forming hexameric channels that connect the IMP to the OMP
contrasts with the established view of the AcrABTolC assem-
bly, in which the tips of the IMP AcrB and OMP TolC directly
interact and themonomers of theMFPAcrA,which contact the
periplasmic domains of both AcrB and TolC, do not interact
with each other, rather than forming a continuous connecting
channel. In support of the hypothesis that more than one MFP
binds per OMP-IMP protomer, we have identified a hexameric
assembly of MtrC (Fig. 4,D and E), with our EM studies reveal-
ing that the six protomers are arranged into a cylindrical struc-
ture (Fig. 4F). However, the internal aperture of the channel
formed by MtrC, at 55 Å, is apparently larger than expected
for 12 helices arranged into a cylinder. For example, the MacA
hexameric assembly has an internal diameter of about 30 Å
(19), whereas TolC has an internal diameter of about 35 Å (8).
To confirm this difference in the apertures of theMtrC and the
FIGURE7. In vivo cross-linkingofMtrCE149C toMtrEK390C.AnSDS-PAGE
gel analysis of the in vivo cross-linking of MtrC D143C and E149C to MtrE
K390C is shown. The wild-type and Cys-less proteins are abbreviatedWT and
CL, respectively. The cells, expressing the MtrC and MtrE derivatives, were
harvested from a 200-ml culture, resuspended to 1 ml, and incubated with 1
mM BMH for 1 h at 25 °C. The cells were washed to remove excess BMH and
sonicated to release the membranes, which were collected by ultracentrifu-
gation and resuspended in 1 ml of cross-linking buffer containing 8 M urea
and 2% DDM. Solubilized membrane proteins were separated from the
membrane debris by ultracentrifugation. To the supernatant, 100 l of Ni2-
Sepharose beads was added; after washing with 10–40 mM imidazole, pro-
teins were eluted from the beads with 50 l of 500 mM imidazole, and 40 l
was loaded onto 4–12% polyacrylamide gel. Protein samples were treated
with 50 mM DTT in an attempt to reduce any disulfide bonds. The gel was
blotted with anti-His tag antibodies to identify complexes of His-tagged
MtrC. As a control, cells co-expressingMtrCE149CorMtrCD143CandCys-less
MtrE were treated with BMH so that any MtrC-MtrE complexes could be dis-
tinguished fromMtrC dimers. Note that cross-linked bands shown were only
present for cells expressing MtrC D143C or E149C and MtrE K390C. The posi-
tions of relevant molecular mass markers are shown on the gel.
FIGURE 8. The tip of the MtrC hairpin interacts with multiple residues
along the intersubunitgrooveofMtrE.A andB, an SDS-PAGEgel analysis of
the cross-linkingofMtrCD143CandE149C toMtrEK390C (A) andMtrCS141C,
D143C, S146C, and E149C toMtrE R239C and R235C (B) with dibromobimane.
The presence of each protein is indicated by a below each gel lane. Note
that onlyMtrCD143C interactedwithMtrE andwas cross-linked to residues at
positions235, 239, and390. For eachgel lane, 20l of an8Mof eachprotein/
0.75 mM DBBR solution was loaded onto a 4–12% polyacrylamide gel. The
positions of relevant molecular mass markers are shown on the gel.
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MacA hexamers, we also visualized the MacA hexamer, con-
firming that this also formed a ring structure but with a smaller
internal diameter of about 34 Å (supplemental Fig. 6). As a
consequence, although the diameter of the MacA hexamer is
insufficient to fit TolC, theMtrC hexamer could accommodate
the MtrE trimer. One possibility is that within the hexamer
formed by MtrC, the interactions between the helices are
stretched, possibly to the point of dissociation, but the assembly
is kept together by interactions between adjacent -domains,
which could be strengthened by dimerization of adjacent hair-
pin domains. Consistent with such a proposal, MtrC dimers,
stabilized by cross-linking, promote assembly of the MtrC-
MtrE complex (Fig. 5A). It is notable that in the structure of the
MacA hexamer, the -domains are arranged into a ring with an
internal diameter of 53 Å (19). If the interaction between adja-
cent hairpin dimers is weaker than between the-domains, this
could allow for a partial dissociation of the complex in which
the hairpin dimer ”fingers“move apart, increasing the apparent
diameter of the hexameric assembly. Indeed, considering that
in the MacA and AcrA structures the helical hairpins are dis-
placed by about 20o fromone another (10, 19) and that previous
studies have revealed that there is conformational flexibility in
AcrA that allows movement of the hairpin relative to the -do-
main (39), it is feasible that the helices can move apart in the
assembled hexamer. This appears to be the case for the CusB
hexamer, in which the hairpins are tethered together at their
base by the lipoyl domains but the hairpins are splayed out at
their periplasmic ends, creating a channel with an aperture of
56Å (9). This is sufficiently large to allow the insertion of the tip
of CusC. It was proposed that this state might represent the
initial interaction of CusC trimer with the CusB hexamer and
that subsequently CusC slides a further 40 Å inside the CusB
hexameric channel so that the CusB hairpins are totally
engagedwithCusC. Recent structural studies of ZneB, theMFP
of the tripartite zinc efflux pump ZneABC, established that it
has a compact crescent shape with bound Zn2 but adopts an
extended linear shape upon releasing the Zn2 (40). Thismight
provide a mechanism for ZneB to ”slide“ across the surface of
the OMP ZneC. Our studies provide some support for such a
two-step interaction in that we have established that a D143C
derivative of MtrC can be cross-linked to the K225C, K390C,
R235C, and R239C derivatives ofMtrE, which are located along
the intersubunit groove in this order from the periplasmic end
to the equatorial region (Fig. 1, supplemental Fig. 3, and Fig. 8).
Considering that Asp-143 is predicted to lie at the tip of the
hairpin, this might suggest that the hairpin domain scans along
the groove during engagement.
Clearly if the coiled-coils of the hairpin domain of theMFP fit
into the intra- and interprotomer grooves, then this interaction
would presumably destabilize the hairpin interactions. How-
ever, this may not preclude the formation of a hexameric
assembly in which three MFP dimers are tethered together by
interactions between adjacent -domains, with one subunit of
the dimer interacting with the intraprotomer groove and the
otherwith the interprotomer groove. Indeed, in the fully assem-
bled tripartite complex, theMFPs are likely to be held together,
via their -domains, by their interaction with the IMP. Consid-
ering that the OMP and consequently the IMP bind a pair of
MFPs, probably as a dimer, which is bound more tightly by the
IMP than the OMP (14, 30), one can envisage a situation where
the trimeric IMP tethers three MFP dimers, which can dynam-
ically associate/dissociate. Dimerization of the hairpin domains
of the MFP could be used to position the second MFP subunit
for binding to the second groove, tightening the interaction of
the dimer as a whole with the OMP. A recent study of the
kinetics of the interaction of AcrA, AcrB, and TolC, indicated
that (i) AcrA forms dimers that interact with AcrB and (ii) the
binary complexes of AcrAB and AcrBTolC can form before the
ternary complex of AcrABTolC, but formation of the AcrA-
TolC complex inhibits ternary complex formation (27). These
findings are suggestive of an ordered assembly of the AcrAB-
TolC ternary complex. Our studies revealed that MtrC binds
MtrD with a much higher affinity than MtrE (30), and consid-
ering that MtrC is anchored to the inner membrane by its
N-terminal -helix, this suggests that the MtrCD binary com-
plexwill formprior to its interactionwithMtrE.One possibility
is thatMtrD contactsMtrE, allowing theMtrCdimers bound to
MtrD to then bind to MtrE. These features of the MFP may
enable it to serve a dual role; having a propensity to formdimers
that can be assembled into hexamers, which can bridge major
facilitator transporters and possibly ABC transporters to their
cognate OMPs, these dimers can disassemble so that they can
interact with the intra- and interprotomer grooves of the cog-
nate OMPs of RND transporters. Indeed, although two recent
studies both reported that AcrA forms dimers, they reached
somewhat conflicting conclusions, with one suggesting that
AcrB interacts with TolC, with AcrA dimers bridging AcrB-
TolC complex (27), whereas the other indicated that the dimers
assemble into a hexameric channel that intervenes between
AcrB and TolC (28). Our studies of MtrCDE allow some of
these conflicting findings to be reconciled and point toward a
general conclusion that tripartite multidrug pumps are assem-
bled with a stoichiometry of 3:6:3.
Previous studies have been interpreted in terms of a trans-
port mechanism in which there are two energetically distinct
steps (35). Firstly, the helical protrusions of the OMP engage
with the exposed periplasmic crown of the IMP to induce a
partial relaxation of helices H7/H8, resulting in partial opening
of the OMP channel and exposure of the intraprotomer groove
of the OMP, which forms part of the binding site for the MFP.
Secondly, the engagement of the MFP with the intraprotomer
groove is thought to disrupt the so-called secondary filter,
which is composed of a double ring of aspartate residues in the
case of TolC, allowing the full opening of the channel (35, 41,
42). Consistent with this mechanism, we established that
although MtrD and MtrE can interact with one another and
with MtrC, the MtrE channel remains locked in the absence of
transported drug substrates (30). Similarly formation of the
AcrABTolC ternary complex has been shown to be independ-
ent of drug binding (27). The mutation of residues within the
intraprotomer groove had the effect of making these mutants
more susceptible to nafcillin, tetracycline, and vancomycin
than control cells that lack the pump (30). Furthermore, these
MtrE mutants, when expressed alone, were insensitive to van-
comycin, but when expressed with MtrC, they became highly
susceptible to vancomycin, indicating that the intraprotomer
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groove has a critical role in controlling opening of the MtrE
channel in response to bindingMtrC, possibly by communicat-
ing its occupancy to the second selective filter, causing it to be
destabilized. Here, we have found that alterations of residues
within the interprotomer groove also have the effect of making
the mutants more susceptible to nafcillin and tetracycline but
had no effect on their vancomycin sensitivity (Table 1 and Fig.
2). Although thismight suggest that theseMtrEmutants simply
lacked the ability to interact with MtrCD, the K225/R239E and
K225E/K390E mtrE double mutants had a much greater sus-
ceptibility to nafcillin and tetracycline than cells expressing
MtrCDalone (Fig. 2), indicating that theMtrCDEpump assem-
bled but was non-functional. Our microcalorimetry studies
confirmed that the K225E/R239E derivative of MtrE was capa-
ble of bindingMtrC (supplemental Fig. 1). Although indicating
that this derivative could be assembled into a tripartite pump, it
is possible that MtrC binds exclusively to the intraprotomer
groove of these derivatives because the interprotomer groove
has been disrupted. In this manner, the pump could become
locked in a non-functional state. Because these mutants were
insensitive to vancomycin, we concluded that the pump was
closed, prohibiting both cellular nafcillin/tetracycline extru-
sion and vancomycin entry (Fig. 2). In contrast, cells expressing
MtrE K390C andMtrC E149C, with wild-typeMtrD, were sen-
sitive to both tetracycline and vancomycin, indicating that an
interaction between the hairpin ofMtrC and the interprotomer
groove ofMtrE could trap an assembly inwhich theMtrE chan-
nel was open (Fig. 6). Consistent with this proposal, MtrC
E149C andMtrE K390C became cross-linked in vivo due to the
formation of a disulfide bond (Fig. 7, lane 4). This disulfide
bond appeared resistant to reduction by DTT, possibly because
the cysteines involved are protected by the formed protein-
protein complex at the intersubunit groove of MtrE and so
inaccessible to DTT (32). However, MtrC E149C could not be
cross-linked to MtrE K390C in vitro with DBBR, suggesting
that this is a transient interaction, which is brought about dur-
ing the closed-to-open conformational change in MtrE. Pre-
sumably, a salt bridge forms between the MtrE Lys-390 and
MtrC Glu-149 during the cycling of MtrE between the closed
and open channel conformations. However, this interaction
cannot be essential because although the MtrE K390E deriva-
tive is impaired in function, the pump is still viable in conferring
resistance, albeit reduced (Fig. 2). On the other hand, combin-
ing this mutation with another mutation, such as K225E, com-
pletely abolished the ability of the pump to confer resistance
(Fig. 2). It appears that disrupting a single salt bridge impairs
the ability of the pump to open and close, but disrupting two
can lock the OMP in the closed conformation. In contrast,
MtrC D143C, which was also capable of forming a disulfide
bond with MtrE K390C (Fig. 7), did not prevent closure of the
MtrE channel (Fig. 2C), and the pump was functional (Fig. 2, A
and B). Moreover, D143C was the only derivative that could be
cross-linked with DBBR to K390C and to R235C and R239C,
which lie further along the intersubunit groove. Presumably by
virtue of its position at the tip of the hairpin, Asp-143 can be
accommodated at various positions within the MtrE groove
without inactivating the pump. These findings highlight the
highly dynamic nature of the interactions of the MFP and its
cognate OMP, and it is likely that they have to reflect the
dynamics of the conformational changes in the IMP, which is
thought to undergo peristaltic cycling during the drug extru-
sion process (43, 44). Intriguingly the importance of the confor-
mational flexibility during the pump function on the level of the
IMP was also recently highlighted by the usage of conditional
cysteine cross-linking (45, 46).
In summary, we demonstrate that a number of surface resi-
dues in theOMPMtrE, which are predicted to line up along the
interprotomer groove, are involved in direct interactions with
the hairpin of its cognateMFPMtrC.Mutations of the residues
of this region appear to have a cumulative effect on the pump
function, and pairwise cysteine cross-links, although not affect-
ing the pump assembly, are able to stall the pump in an inactive
state. These findings are consistent with an accumulating body
of evidence that tripartite pumps may assemble in stoichiome-
tries higher than 3:3:3 (20–24, 27, 28, 47) and indicate an active
role of the MFP in controlling the conformational changes in
the OMP to elicit channel opening for drug extrusion.
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